Determination of Tiopronin in Human Plasma and Study on Its Bioequivalence
Hou Yan-ning
Abstract
Hou Yan-ning
Abstract
OBJECTIVE To study the pharmacokinetics and bioequivalence of tiopronin tablets in healthy volunteers.METHODS In a randomized crossover study,18 healthy male volunteers were given a single oral dose of 200 mg test and reference tablets.Tiopronin in plasma was determined by a LC-MS method.RESULTS The main pharmacokinetic parameters for tiopronin of reference and test preparations in plasma were as follows:ρmax were(3.54±0.75) and(3.27±1.03) mg·L-1;tmax were(4.6±1.1) and(4.3±1.0) h;AUC0-96 h were(18.2±4.5) and(17.6±5.9) mg·h·L-1;AUC0-∞ were(20.4±5.5) and(19.9 ± 6.9) mg·h·L-1;t1/2 were(39.4±14.3) and(41.8±16.5) h,respectively.The relative bioavailability of tiopronin was(95.7±26.1)%.CONCLUSION The test and reference preparations were bioequivalent.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE To study the pharmacokinetics and bioequivalence of tiopronin tablets in healthy volunteers.METHODS In a randomized crossover study,18 healthy male volunteers were given a single oral dose of 200 mg test and reference tablets.Tiopronin in plasma was determined by a LC-MS method.RESULTS The main pharmacokinetic parameters for tiopronin of reference and test preparations in plasma were as follows:ρmax were(3.54±0.75) and(3.27±1.03) mg·L-1;tmax were(4.6±1.1) and(4.3±1.0) h;AUC0-96 h were(18.2±4.5) and(17.6±5.9) mg·h·L-1;AUC0-∞ were(20.4±5.5) and(19.9 ± 6.9) mg·h·L-1;t1/2 were(39.4±14.3) and(41.8±16.5) h,respectively.The relative bioavailability of tiopronin was(95.7±26.1)%.CONCLUSION The test and reference preparations were bioequivalent.
Key concepts: Bioequivalence, Tiopronin, Pharmacokinetics, Bioavailability, Crossover study, Pharmacology, Plasma concentration, Chemistry